The home health nurse is caring for a 77-year-old patient with ...

[burchfield96]

The home health nurse is caring for a 77-year-old patient with congestive heart failure. What would the nurse consider a priority to assess to develop the most effective plan of care related to medication administration?
 
  A) Description of the patient's living environment
  B) Required lifestyle changes
  C) Family members in the community
  D) Compliance with therapy to reduce risk of skin breakdown

Question 2

The nurse is caring for a patient at risk of severe-to-fatal interstitial lung disease. What antineoplastic agent is the nurse administering that carries this risk?
 
  A) Valrubicin (Valstar)
  B) Erlotinib (Tarceva)
  C) Histrelin acetate (Vantas)
  D) Triptorelin pamoate (Trelstar Depot)

[bassamabas]

Answer to Question 1

B
Feedback:
Nurses must consider how a person responds to disease and its treatment, including the changes in lifestyle that may be required. By recognizing required lifestyles during the home visit the nurse can teach the patient how to make healthy choices and support the process of changing to new choices. Although the environment would impact the physical plan of care, it would not be a factor in the administration of medications. Assessment of family members in the community would not be a necessary part of the assessment in relation to the patient's drug therapy. Nothing suggests the patient is at risk for skin breakdown so this would not factor into the medication regimen.

Answer to Question 2

B
Feedback:
Erlotinib inhibits tyrosine kinase associated with epidermal growth factor found on surfaces of normal and cancer cells and causes serious-to-fatal interstitial lung disease. Histrelin inhibits gonadotropic secretion and decreases follicle-stimulating hormone (FSH) and luteinizing hormone (LH) and testosterone levels and suppresses testosterone production. Hot flashes are very common with this drug. Triptorelin pamoate decreases FSH and LH levels and also suppresses testosterone production. It has also been associated with sexual dysfunction, urinary tract symptoms, bone pain, and hot flashes. Valrubicin is used in intravesical therapy for carcinoma in situ of the bladder. It is also associated with severe bladder spasms.